The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Apogee Therapeutics Inc (NASDAQ: APGE) closed at $39.39 in the last session, down -1.82% from day before closing price of $40.12. In other words, the price has decreased by -$1.82 from its previous closing price. On the day, 0.5 million shares were traded.
Ratios:
We take a closer look at APGE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 18.55 and its Current Ratio is at 18.55. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $95.
On November 25, 2024, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $89.
On May 10, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $80.BofA Securities initiated its Buy rating on May 10, 2024, with a $80 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 02 ’25 when Dambkowski Carl sold 3,860 shares for $36.22 per share. The transaction valued at 139,801 led to the insider holds 247,173 shares of the business.
CARL DAMBKOWSKI bought 9,310 shares of APGE for $331,529 on Apr 02 ’25. On Mar 05 ’25, another insider, Dambkowski Carl, who serves as the Chief Medical Officer of the company, sold 1,590 shares for $30.48 each. As a result, the insider received 48,463 and left with 251,033 shares of the company.
Stock Price History:
Over the past 52 weeks, APGE has reached a high of $63.50, while it has fallen to a 52-week low of $26.20. The 50-Day Moving Average of the stock is 9.73%, while the 200-Day Moving Average is calculated to be -12.20%.
Shares Statistics:
A total of 45.99M shares are outstanding, with a floating share count of 36.22M. Insiders hold about 37.94% of the company’s shares, while institutions hold 83.49% stake in the company.
